课题基金 / 基金详情

Integrated Training in Quantitative and Experimental Cancer Systems Biology

Integrated Training in Quantitative and Experimental Cancer Systems Biology
定量和实验癌症系统生物学综合培训
批准号:
10090506
负责人:
LISA M. COUSSENS
金额:
$24.25万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-02-01 至 2026-01-31

项目摘要

项目成果

LISA M. COUSSENS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary There is an outstanding need for a national cadre of quantitatively sophisticated oncologists, with deep training in both biological aspects of cancer and computational tools to further understanding and treatment. In the proposed training program, OHSU will leverage the strengths of both its cancer program, ranging from basic science to translation, and its computational capacity, spanning from genomics to mechanistic modeling. OHSU was recently ranked as the top young university in life sciences research in the world in the Nature Index. A key strength of the training program will be required co-mentorship by both quantitative and wet-lab basic or clinical faculty. Post-doctoral trainees arriving with expertise in either biology or computation will receive extensive training in the complementary field, both didactic and research-based. Graduate trainees will engage both fields from day one in a specially designed curriculum building on existing courses and established faculty expertise, centered in the Departments of Biomedical Engineering and the Department of Cell, Developmental & Cancer Biology. The training faculty have outstanding track records in mentorship and research productivity, complemented by a healthy cohort of junior faculty to maintain program viability over the long term. Nearly 40 faculty will initially be available to trainees, with an average of >$800,000/year in research funding.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Integrated Training in Quantitative and Experimental Cancer Systems Biology
Integrated Training in Quantitative and Experimental Cancer Systems Biology
Delineation of Leukocyte Biomarkers for Human Breast Cancer Outcome
Vevo 2100 Ultrasound System
海外基金